CLINICAL_TRIALS
trial_result
· 2019-11-06
Clinical Trial Update: CuATSM Compared With Placebo for Treatment of ALS/MND [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluating CuATSM versus placebo for amyotrophic lateral sclerosis (ALS) is ongoing, with an unknown current status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Collaborative Medicinal Development Pty Limited | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: UNKNOWN